Boston, MA -- (SBWIRE) -- 08/29/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Newcastle Investment Corp. (NYSE:NCT), Monster Worldwide, Inc. (NYSE:MWW), Pan American Silver Corp. (USA) (NASDAQ:PAAS), Astex Pharmaceuticals, Inc. (NASDAQ:ASTX)
Newcastle Investment Corp. (NYSE:NCT) shares declined 0.94% to $5.29. The company on August 7 reported that its second-quarter net income increased to $52.33 million or $0.20 per share, from $29.04 million or $0.21 per share, last year. Core earnings were $43.0 million or $0.16 per share, for the quarter. Income from continuing operations rose to $28.14 million or $0.10 per share, from $23.82 million or $0.17 per share, a year ago. Net interest income decreased to $40.83 million from $48.49 million last year.
How Should Investors Trade NCT After The Recent Volatility? Get Free Report Here
Monster Worldwide, Inc. (NYSE:MWW) shares jumped 9.37% to $4.67. Monster.com, the flagship brand of Monster Worldwide, Inc. (NYSE:MWW), and GfK, an independent global market research company, on August 29 released new survey data shedding light on millennial-aged Americans' sentiment toward work and how they differ from their older colleagues in the workplace. While one may think careers would be valued most by Generation X or baby boomers, they are surprisingly valued most by America's youngest generation. When it comes to having a Career vs. a Job, millennials aged 18-30 are the most positive (62%) that having a career is very much a reality in today's work environment, even for America's youngest workers.
How Should Investors Trade MWW After The Recent Volatility? Get Free Report Here
Pan American Silver Corp. (USA) (NASDAQ:PAAS) shares gained 0.16% to $12.55. The company’s Board of Directors has approved the third quarterly cash dividend of 2013 in the amount of $0.125 per common share. Should the Company's Board of Directors continue to approve future quarterly dividends in the same amount, the annual cash dividend paid by Pan American would be $0.50 per common share, which represents a yield of approximately 3.6% based on the Company's closing share price on August 14, 2013.
Is PAAS A Good Buy After The Recent Price Movement? Find Out Here
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) shares gained 0.44% to $6.85. The company, on August 28, announced topline results from the ongoing phase 2 of SGI-110 in patients with AML and MDS. The Phase 2 study is a randomized study of SGI-110 given either as 60 or 90 mg/m2 daily for 5 days in a 28-day course. As of end of June data cutoff, 67 AML patients had a minimum follow up of 3 months (50 patients representing the complete cohort of relapsed/refractory AML, and 17 patients in the treatment-naive elderly AML not suitable for induction chemotherapy cohort). The primary endpoint is overall remission rate (Complete Remission or CR; Complete Remission with Incomplete hematologic recovery or CRi/CRp).
Is ASTX A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)